Literature DB >> 20403353

Functional signaling of membrane-bound TL1A induces IFN-gamma expression.

Eva Biener-Ramanujan1, Rivkah Gonsky, Brian Ko, Stephan R Targan.   

Abstract

TL1A, a TNF member implicated in autoimmune diseases, is a transmembrane protein that is processed to release soluble TL1A (TL1A-S). TL1A-S induces a Th1 response, although the functional significance of membrane-bound TL1A (TL1A-M) remains unknown. We generated TL1A-M expression in HEK-293 cells capable of binding DR3-Fc. Co-incubating IL-12/IL-18-primed CD4(+) T cells with HEK-293 cells expressing TL1A-M induced 3-fold increase in IFN-gamma that was blocked by anti-TL1A Ab. These results demonstrate that TL1A-M can bind death domain receptor 3 (DR3) through cell-cell contact to induce downstream IFN-gamma secretion enhancement. Anti-TL1A antibodies designed to treat immune diseases should be verified to block both endogenous TL1A forms. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403353     DOI: 10.1016/j.febslet.2010.04.030

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.

Authors:  Byung-Su Kim; Hidekazu Nishikii; Jeanette Baker; Antonio Pierini; Dominik Schneidawind; Yuqiong Pan; Andreas Beilhack; Chung-Gyu Park; Robert S Negrin
Journal:  Blood       Date:  2015-06-10       Impact factor: 22.113

2.  Constitutive TL1A (TNFSF15) expression on lymphoid or myeloid cells leads to mild intestinal inflammation and fibrosis.

Authors:  David Q Shih; Robert Barrett; Xiaolan Zhang; Nicole Yeager; Hon Wai Koon; Piangwarin Phaosawasdi; Yahui Song; Brian Ko; Michelle H Wong; Kathrin S Michelsen; Gislaine Martins; Charalabos Pothoulakis; Stephan R Targan
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

3.  TNFSF15 Modulates Neovascularization and Inflammation.

Authors:  Zhisong Zhang; Lu-Yuan Li
Journal:  Cancer Microenviron       Date:  2012-07-26

4.  Cleavage of TL1A Differentially Regulates Its Effects on Innate and Adaptive Immune Cells.

Authors:  John R Ferdinand; Arianne C Richard; Françoise Meylan; Aymen Al-Shamkhani; Richard M Siegel
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

5.  SUSTAINED TL1A (TNFSF15) EXPRESSION ON BOTH LYMPHOID AND MYELOID CELLS LEADS TO MILD SPONTANEOUS INTESTINAL INFLAMMATION AND FIBROSIS.

Authors:  Libo Zheng; Xiaolan Zhang; Jeremy Chen; Ryan Ichikawa; Kori Wallace; Charalabos Pothoulakis; Hon Wai Koon; Stephan R Targan; David Q Shih
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-03

6.  First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects.

Authors:  Christopher Banfield; Dan Rudin; Indranil Bhattacharya; Kosalaram Goteti; Gang Li; Mina Hassan-Zahraee; Lisa S Brown; Kenneth E Hung; Sylvester Pawlak; Christopher Lepsy
Journal:  Br J Clin Pharmacol       Date:  2020-01-28       Impact factor: 4.335

7.  T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells.

Authors:  Judith Leitner; Werner Kuschei; Katharina Grabmeier-Pfistershammer; Ramona Woitek; Ernst Kriehuber; Otto Majdic; Gerhard Zlabinger; Winfried F Pickl; Peter Steinberger
Journal:  J Immunol Methods       Date:  2010-09-19       Impact factor: 2.303

8.  The TL1A-DR3 Axis in Asthma: Membrane-Bound and Secreted TL1A Co-Determined the Development of Airway Remodeling.

Authors:  Jintao Zhang; Dong Zhang; Yun Pan; Xiaofei Liu; Jiawei Xu; Xinrui Qiao; Wenjing Cui; Liang Dong
Journal:  Allergy Asthma Immunol Res       Date:  2022-03       Impact factor: 5.764

9.  Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.

Authors:  Ludovica F Buttó; Li-Guo Jia; Kristen O Arseneau; Hiroshi Tamagawa; Alex Rodriguez-Palacios; Zhaodong Li; Carlo De Salvo; Theresa T Pizarro; Giorgos Bamias; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2019-01-01       Impact factor: 5.325

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.